OSE Pharma SA - Asset Resilience Ratio

Latest as of June 2025: 29.41%

OSE Pharma SA (OSE) has an Asset Resilience Ratio of 29.41% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See OSE current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

€30.64 Million

≈ $35.82 Million USD Cash + Short-term Investments

Total Assets

€104.18 Million

≈ $121.80 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2015–2024)

This chart shows how OSE Pharma SA's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see OSE Pharma SA asset portfolio.

Liquid Assets Composition Over Time

This chart breaks down OSE Pharma SA's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore OSE Pharma SA (OSE) long-term investment share to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	€14.44 Million	13.86%
Short-term Investments	€16.20 Million	15.55%
Total Liquid Assets	€30.64 Million	29.41%

Asset Resilience Insights

Very High Liquidity: OSE Pharma SA maintains exceptional liquid asset reserves at 29.41% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

OSE Pharma SA Industry Peers by Asset Resilience Ratio

Compare OSE Pharma SA's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
argenx NV ADR NASDAQ:ARGX	Biotechnology	15.95%
Ligand Pharmaceuticals Incorporated NASDAQ:LGND	Biotechnology	16.06%
Genscript Biotech Corporation F:G51	Biotechnology	13.79%
Xiamen Amoytop Biotech Co Ltd SHG:688278	Biotechnology	4.69%
BB Biotech AG SW:BION	Biotechnology	92.97%
89bio Inc NASDAQ:ETNB	Biotechnology	71.60%
Pacific Shuanglin Bio pharmacy Co Ltd SHE:000403	Biotechnology	2.66%
Vor Biopharma Inc NASDAQ:VOR	Biotechnology	74.48%

Annual Asset Resilience Ratio for OSE Pharma SA (2015–2024)

The table below shows the annual Asset Resilience Ratio data for OSE Pharma SA.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	41.70%	€51.69 Million ≈ $60.43 Million	€123.96 Million ≈ $144.92 Million	+26.38pp
2023-12-31	15.32%	€12.57 Million ≈ $14.69 Million	€82.05 Million ≈ $95.93 Million	+7.56pp
2022-12-31	7.75%	€7.11 Million ≈ $8.31 Million	€91.67 Million ≈ $107.17 Million	-25.10pp
2021-12-31	32.85%	€33.35 Million ≈ $38.99 Million	€101.52 Million ≈ $118.69 Million	+3.00pp
2020-12-31	29.86%	€28.91 Million ≈ $33.80 Million	€96.85 Million ≈ $113.22 Million	+1.01pp
2019-12-31	28.85%	€25.64 Million ≈ $29.98 Million	€88.89 Million ≈ $103.92 Million	+18.50pp
2018-12-31	10.35%	€7.96 Million ≈ $9.30 Million	€76.90 Million ≈ $89.91 Million	-2.96pp
2017-12-31	13.31%	€10.29 Million ≈ $12.03 Million	€77.35 Million ≈ $90.43 Million	-6.53pp
2016-12-31	19.84%	€17.77 Million ≈ $20.77 Million	€89.55 Million ≈ $104.69 Million	-14.29pp
2015-12-31	34.13%	€5.80 Million ≈ $6.78 Million	€17.00 Million ≈ $19.87 Million	--

pp = percentage points

About OSE Pharma SA

PA:OSE France Biotechnology

Market Cap

$68.94 Million

€58.97 Million EUR

Market Cap Rank

#20784 Global

#323 in France

Share Price

€2.63

Change (1 day)

-0.60%

52-Week Range

€2.61 - €7.20

All Time High

€15.00